Physician profile
John A Buza
NPI 1760827976
$7,091.69
in general payments reported to CMS, 2019-2025
14 companies · $352 in 2025
The $352 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,121 · 2020: $769 · 2021: $1,051 · 2022: $49.68 · 2023: $578 · 2024: $1,171 · 2025: $352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,575 · Travel and Lodging: $527.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,574.82 |
| Travel and Lodging | $526.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,822.19 | 2019-2025 | Mako, Gamma, N/A |
| Nuvasive, INC. | $1,509.58 | 2019-2021 | |
| Medtronic, INC. | $1,077.70 | 2021-2025 | Kyphon Express II Kyphopak Tray, Cd Horizon Spinal System, O-Arm |
| Medical Device Business Services, INC. | $861.80 | 2019 | |
| Medtronic USA, INC. | $735.34 | 2019-2020 | |
| Spineology INC. | $234.34 | 2023 | Optimesh Expandable Interbody Fusion System |
| Acumed LLC | $213.67 | 2024 | Inframe Implant, Acumed |
| Depuy Synthes Sales INC. | $181.40 | 2019-2023 | Conduit |
| Boston Scientific Corporation | $164.04 | 2024 | |
| Si-Bone, INC. | $122.11 | 2020 | |
| Orthofix Medical, INC. | $82.87 | 2022-2025 | Cervical-Stim, Spinal-Stim |
| Titan Spine, LLC | $36.00 | 2019 | |
| Ethicon US, LLC | $31.21 | 2019 | |
| Exactech, INC. | $19.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Buza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.